Specifications of pomalidomide

Pomalidomide (Pomalidomide), as a type of immunomodulator, is commonly used in combination regimens for multiple myeloma (MM) in international guidelines. Its specifications are designed very carefully to allow for flexible dose adjustment in different stages and different tolerance levels of treatment.

The common specifications of drugs around the world mainly include Four dosages of 1mg, 2mg, 3mg and 4mg, each dosage is subdivided into two types of bottles: 21 capsules and 100 capsules. In routine treatment, patients often use 21-capsule packaging for periodic medication, while the 100-capsule packaging is more suitable for long-term prescription needs or centralized management in hospital departments, and can provide a more sufficient inventory for dose adjustment. The design of these specifications is closely related to the fact that pomalidomide needs to be taken in a periodic and intermittent manner, and also allows doctors to conduct treatment based on patient tolerance, blood picture changes, and renal function.

Capsules of different dosages are usually distinguished by different colors or numbers in appearance, making it easier for medical teams and patients to avoid medication confusion. The bottles of international original drugs are strictly sealed and come with risk management warnings, mainly because pomalidomide has certain teratogenicity and needs to be distributed under strict supervision. In many overseas regions, pomalidomide has been included in the safety monitoring system, requiring patients to confirm that there is no pregnancy risk and receive relevant education before use. This is also one of the important reasons why its packaging specifications are subdivided.

From the perspective of drug stability and transportation, the use of bottled airtight containers for pomalidomide can effectively reduce the potential impact of light and humidity on the capsules and ensure the consistency of the drug effect throughout the entire treatment cycle. Each bottle of medicine comes with a batch number and expiration date to ensure traceability of pharmaceutical quality. Because pomalidomide is a highly controlled drug, it is usually not packaged in bulk or non-closed packaging in the international market to prevent misuse, moisture deterioration and risk leakage.

Reference materials:https://en.wikipedia.org/wiki/Pomalidomide